Aerovate Therapeutics, Inc.
AVTE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$70 | -$76 | -$52 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $12 | $5 | $2 |
| Change in WC | -$11 | $10 | $8 | -$7 |
| Other Non-Cash | -$2 | -$3 | -$1 | $0 |
| Operating Cash Flow | -$71 | -$57 | -$39 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$20 | -$124 | -$148 | -$113 |
| Inv. Sales/Matur. | $76 | $136 | $155 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $56 | $12 | $7 | -$113 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $24 | $45 | $0 | $127 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $2 | $0 | $64 |
| Financing Cash Flow | $25 | $46 | $0 | $190 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10 | $1 | -$32 | $50 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23 | $22 | $54 | $5 |
| End Cash | $34 | $23 | $22 | $54 |
| Free Cash Flow | -$71 | -$57 | -$39 | -$28 |